Using the MMPI-2 to Detect Substance Abuse in an Outpatient Mental Health Setting



Similar documents
SUBSTANCE ABUSE QUESTIONNAIRE SHORT FORM (SAQ-Short Form)

DUI Arrests, BAC at the Time of Arrest and Offender Assessment Test Results for Alcohol Problems

Associations between MMPI-2-RF PSY-5 Scale Scores and Therapist-rated Success in Treatment

Residential SOAP and Inpatient Dual Diagnosis Comparisons Consumer Satisfaction Report, Addendum to Inpatient Aggregate Report

YOUNG ADULTS IN DUAL DIAGNOSIS TREATMENT: COMPARISON TO OLDER ADULTS AT INTAKE AND POST-TREATMENT


[Appellant] Psychology Technician, GS Department of Veterans Affairs Veterans Health Administration [Installation] [City, State]

RECENT epidemiological studies suggest that rates and

Glossary of Terms Ability Accommodation Adjusted validity/reliability coefficient Alternate forms Analysis of work Assessment Battery Bias

The relationship among alcohol use, related problems, and symptoms of psychological distress: Gender as a moderator in a college sample

Executive Summary. 1. What is the temporal relationship between problem gambling and other co-occurring disorders?

How To Find Out How Different Groups Of People Are Different

Clinical Treatment Protocol For The Integrated Treatment of Pathological Gamblers. Presented by: Harlan H. Vogel, MS, NCGC,CCGC, LPC

General Symptom Measures

Classification Appeal Decision Under section 5112 of title 5, United States Code

African American Women and Substance Abuse: Current Findings

PII S (97) BRIEF REPORT

Colorado Substance Abuse Treatment Clients with Co-Occurring Disorders, FY05

Treatment for Adolescent Substance Use Disorders: What Works?

Running Head: INTERNET USE IN A COLLEGE SAMPLE. TITLE: Internet Use and Associated Risks in a College Sample

Client Population Statistics

Special Populations in Alcoholics Anonymous. J. Scott Tonigan, Ph.D., Gerard J. Connors, Ph.D., and William R. Miller, Ph.D.

With Depression Without Depression 8.0% 1.8% Alcohol Disorder Drug Disorder Alcohol or Drug Disorder

SOCIAL WORK RESEARCH ON INTERVENTIONS FOR ADOLESCENT SUBSTANCE MISUSE: A SYSTEMATIC REVIEW OF THE LITERATURE

SUBSTANCE ABUSE TREATMENT PROGRAMS AT THE CORRECTIONS CENTER OF NORTHWEST OHIO

Department of Community and Human Services Mental Health, Chemical Abuse and Dependency Services Division

FRN Research Report March 2011: Correlation between Patient Relapse and Mental Illness Post-Treatment

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

American Society of Addiction Medicine

UNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015

Measurement & Data Analysis. On the importance of math & measurement. Steps Involved in Doing Scientific Research. Measurement

CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia

Key Questions to Consider when Seeking Substance Abuse Treatment

Dual Diagnosis Capability

Suicide Assessment in the Elderly Geriatric Psychiatric for the Primary Care Provider 2008

Partial Hospitalization - MH - Adult (Managed Medicaid only Service)

Abstract. Introduction

PCO 6317: Psychological Assessment 2 (Personality) Spring 2013 * Wednesdays 10:40 am - 1:40 pm * CWC 231

Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study for DWI Offenders

Root Cause Analysis of Addiction: An Ongoing Study ERIC J. KOCIAN, PH.D. SAINT VINCENT COLLEGE JULY 21, 2015

Treatment Research Institute 600 Public Ledger Building, 150 S. Independence Mall West Philadelphia, PA (800 )

Treatment of Alcoholism

Client Intake Information. Client Name: Home Phone: OK to leave message? Yes No. Office Phone: OK to leave message? Yes No

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction

Using a Mental Measurements Yearbook Review to Evaluate a Test

DRAFT Metropolitan Detention Center (MDC) DWI Addiction Treatment Programs (ATP) Outcome Study Final Report UPDATED

OXFORD HOUSE: DEAF-AFFIRMATIVE SUPPORT

The Begun Center is currently serving as the evaluator for five drug courts in Ohio receiving SAMHSA grant funding.

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

JUVENILE AUTOMATED SUBSTANCE ABUSE EVALUATION REFERENCE GUIDE

PREDICTORS OF NON-EPILEPTIC SEIZURES IN AN INPATIENT EPILEPSY PROGRAM

Continuous Performance Test 3 rd Edition. C. Keith Conners, Ph.D.

Factors Related To Psychiatric Hospitalization and Repeated Crisis Service Use By Dually- Diagnosed Persons

Family Law Toolkit for Survivors The Domestic Violence & Mental Health Collaboration Project

Results from the 2009 National Survey on Drug Use and Health: Mental Health Findings

COMPARISONS OF CUSTOMER LOYALTY: PUBLIC & PRIVATE INSURANCE COMPANIES.

How To Stop A Destructive Cycle Through Behavioral Couples Therapy

The Roles of School Psychologists Working Within a Pediatric Setting

Courses Descriptions. Courses Generally Taken in Program Year One

Revised April 1, 2015 Page 1 of 5

DRUG AND ALCOHOL TREATMENT IN BARBADOS. By: Laura Lee Foster National Council on Substance Abuse

Brenau University Psychology Department Thesis Components Checklist

A Descriptive Study of Depression, Substance Abuse, and Intimate Partner Violence Among Pregnant Women

Running head: ASPERGER S AND SCHIZOID 1. A New Measure to Differentiate the Autism Spectrum from Schizoid Personality Disorder

Suicide, PTSD, and Substance Use Among OEF/OIF Veterans Using VA Health Care: Facts and Figures

Substance Abuse Treatment Admissions for Abuse of Benzodiazepines

Results from the 2010 National Survey on Drug Use and Health: Mental Health Findings

Applied Psychology. Course Descriptions

Phoenix House. Outpatient Treatment Services for Adults in Los Angeles and Orange Counties

Case Description: Mr. F Personnel Screening, Law Enforcement Score Report

Day Treatment Mental Health Adult

Behavioral Health Rehabilitation Services: Brief Treatment Model

STATISTICS FOR PSYCHOLOGISTS

Psychology Externship Program

Documentation Guidelines for ADD/ADHD

A PROSPECTIVE EVALUATION OF THE RELATIONSHIP BETWEEN REASONS FOR DRINKING AND DSM-IV ALCOHOL-USE DISORDERS

Addiction Psychiatry Fellowship Rotation Goals & Objectives

What is Addiction? DSM-IV-TR Substance Abuse Criteria

Substance Abuse Treatment Record Review Presentation

Running head: SAMPLE FOR STUDENTS 1. Sample APA Paper for Students Interested in Learning APA Style 6th Edition. Jeffrey H. Kahn

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES

The Pre-employment Clinical Assessment of Police Candidates: Principles and Guidelines for Canadian Psychologists. April, 2013

Fax # s for CAMH programs and services

Treatment. Race. Adults. Ethnicity. Services. Racial/Ethnic Differences in Mental Health Service Use among Adults. Inpatient Services.

Concurrent Disorder Comprehensive Assessment: Every Interaction is an Intervention

CO-OCCURRING DISORDERS. Michaelene Spence MA LADC 8/8/12

Behavioral Health Services 14.0

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

M.A. EDUCATIONAL PSYCHOLOGY

Fourth Judicial District of Minnesota Pretrial Evaluation: Scale Validation Study

Abbas S. Tavakoli, DrPH, MPH, ME 1 ; Nikki R. Wooten, PhD, LISW-CP 2,3, Jordan Brittingham, MSPH 4

Transcription:

Psychological Assessment 1999, Vol. 11, No. 1,94- Copyright 1999 by the American Psychological Association, Inc. 1040-3590/99/S3.00 Using the MMPI-2 to Detect Substance Abuse in an Outpatient tal Health Setting L. A. R. Stein, John R. Graham, Yossef S. Ben-Porath, and John L. McNulty Kent State University This study examined the utility of the MMPI-2 in detecting substance-abuse problems in an outpatient mental health setting. Specifically, the utility of the Addiction Acknowledgment (; N. C. Weed, J. N. Butcher, T. McKenna, & Y. S. Ben-Porath, 1992), the Addiction Potential (; N. C. Weed et al., 1992), and the MacAndrew Alcoholism Revised (; J. N. Butcher, W. G. Dahlstrom, J. R. Graham, A. Tellegan, & B. Kaemmer, 1989) in the prediction of substance abuse was evaluated. In addition, the incremental validity of the and the in comparison to the scale was evaluated. The sample consisted of 500 women and 333 men from a large community mental health center in Northeastern Ohio. Results indicated that the scale, the, and the were related to interviewer ratings of substance abuse in this outpatient treatment setting. Specifically, the results pointed to the superiority of over in substance-abuse identification and the significant contribution of to the information available from the scale alone. Alcohol and drag use and abuse at times are an integral part of problems presented by clients at outpatient mental health clinics. These difficulties may go undetected when they are not the primary reason for referral, as might be the case in primary mental health settings (Weed, Butcher, McKenna, & Ben-Porath, 1992). One of the most widely used instruments for assessing mental health problems in such settings is the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989). This study examined the utility of the MMPI-2 in detecting substance-abuse problems in an outpatient setting where substance abuse is not the primary focus of treatment. The MacAndrew Alcoholism (MAC; MacAndrew, 15) of the original MMPI was developed to differentiate alcoholic from nonalcoholic psychiatric patients. The scale was constructed by contrasting the MMPI responses of 200 male alcoholics seeking treatment at an outpatient clinic with 200 male nonalcoholic psychiatric patients from the same facility. MacAndrew (1981) reviewed more than two dozen studies that demonstrated the ability of the MAC scale to differentiate alcoholic from nonalcoholic participants. The scale seems to be effective with men and women, as well as inpatients and outpatients (Graham & Stronger, 1988). Gottesman and Prescott (1989) indicated that the routine use of the MAC scale to identify substance abusers is not as compelling as many users had assumed. They noted poor construct and predictive validity. However, most of the studies reviewed by them used a cutoff score of 24 in discriminating abusers from nonabusers, whereas Graham (1993) recommended a cutoff of 28. In addition, as Graham (1993) pointed out, Gottesman and Prescott (1989) seemed to imply that professionals would decide whether or not a person abuses substances on the basis of MMPI (or L. A. R. Stein, John R. Graham, Yossef S. Ben-Porath, and John L. McNulty, Department of Psychology, Kent State University. Correspondence concerning this article should be addressed to L. A. R. Stein, who is now at the Center for Alcohol and Addiction Studies, Box G-BH, Brown University, Providence, Rhode Island 022. 94 MMPI-2) data alone. As Graham (1993) recommended, no decisions should be made on the basis of MMPI (or MMPI-2) data alone, and high scores on MAC (or ) should alert clinicians to obtain corroborating data regarding the possibility of substance abuse. With the development of the MMPI-2, four of the original MAC items were among those eliminated from the test because of objectionable content. These items were replaced with four new items selected because they differentiated alcoholic from nonalcoholic men and women. The revised scale is labeled (Butcher, Dahlstrom, Graham, Tellegan, & Kaemmer, 1989). In an effort to expand the assessment of alcohol and drug problems with the broader item pool of the MMPI-2, the Addiction Potential () and the Addiction Acknowledgment () were developed (Weed et al., 1992). The consists of 39 items that were endorsed differently by substance abusers compared with both nonclinical and psychiatric inpatient samples. In an effort to avoid reliance on obvious content in abuse potential determination, items were eliminated from the if they contained obvious reference to substance abuse. The, a 13-item content-based scale, was constructed, using rational item selection augmented by internal consistency procedures (Weed et al.). Items were selected for the because of their obvious content relation to substance abuse and, therefore, it is a more face-valid scale than the. Weed et al. (1992) presented data showing that the and discriminated well between substance-abuse, nonclinical, and psychiatric samples and did so substantially better than the scale. Specifically, the appeared to discriminate between the substance-abuse and nonclinical samples better than the, whereas the appeared to distinguish between substance-abuse and psychiatric samples better than the. Weed et al. noted that their findings were limited because the samples used in development and cross-validation of the and came from the same settings. Greene, Weed, Butcher, Arrendondo, and Davis (1992) found that in a different setting the discriminated between psychiatric inpatients and substance-abuse

SUBSTANCE ABUSE AND THE MMPI-2 95 samples more effectively than the and that both scales discriminated better than the scale. However, although Weed et al. found the scale to be quite ineffective at discriminating between psychiatric and substance-abuse samples, results presented by Greene et al. (1992) indicated that the scale discriminated between psychiatric and substanceabuse samples, effectively. In addition, the magnitude of discrimination by the in the study conducted by Greene et al. was less than in the study conducted by Weed et al. No study to date has directly addressed the utility of the and in assessing substance abuse in an outpatient mental health setting where substance abuse, although often of considerable relevance, is not the primary focus of the assessment. It is important to continue efforts to validate the and with a variety of samples, including clients in outpatient settings. In addition, as recommended by Butcher, Graham, and Ben-Porath (1995), new MMPI-2 scales should add significantly to prediction of relevant behaviors and characteristics beyond what is possible using existing scales. The purpose of this study was to explore the effectiveness of the scale, the, and the in the identification of substance abuse, and to examine the incremental validity of the and in comparison to the scale in an outpatient mental health facility where substance abuse is not the primary focus of treatment. On the basis of the body of research available about the MAC/ scale (for a summary of this research, see Graham, 1993), and the research regarding the and reviewed above, we expected that the scale, the, and the would all be effective in identifying substance abuse. This study was conducted in an effort to determine which scale or scales are most effective in an outpatient setting where substance abuse is not the primary focus of treatment, and the extent to which the new MMPI-2 substance abuse scales add incrementally to the in identifying substance abusers in this setting. Participants Methods Data were collected at a large community mental health center (CMHC) in Northeast Ohio. A variety of treatment programs was available for the clients, including partial hospitalization and individual and group outpatient treatment. Clients with substance abuse as a primary problem were referred elsewhere. However, the CMHC served dually diagnosed clients who did not have a substance-abuse disorder as the primary diagnosis. A specialized program was available for these clients involving individual counseling, psychoeducational group intervention, family therapy, support groups, and referral to Alcoholics Anonymous, Narcotics Anonymous, and Al-Anon. On the basis of an in-depth interview during intake, and where possible, previous treatment records, the determination was made as to whether substance abuse was a primary or secondary problem. The sample used in this study was a subset of a larger sample collected by Graham, Ben-Porath, and McNulty (in press). The larger sample included all persons seeking services at the mental health center from April 19 through December 1992 and included 1,035 men and 1,447 women. Out of a total of 2,482 clients seeking services at the CMHC, 1,263 participants did not receive services beyond intake and so did not complete the MMPI-2. Valid MMPI-2 profiles were defined as follows: Cannot say raw score <31, Variable Response Inconsistency T score <81, and True Response Inconsistency raw score between 6 and 12, inclusive (Butcher et al., 1989); and F raw score <29 for women, F raw score <27 for men, Back F raw score <24 for women, and Back F raw score <23 for men (Graham, Watts, & Timbrook, 19). Clients who produced a valid MMPI-2 and for whom intake ratings were available concerning relevant substance-abuse data were identified as candidates for this study. Of the 501 men and the 718 women who completed the MMPI-2, 410 men and 610 women produced valid profiles. Of the 1,020 clients who produced valid MMPI-2s, 77 men and 110 women did not have completed intake ratings regarding substance-abuse history and were eliminated. The current study's sample consisted of 500 women and 333 men who produced a valid MMPI-2 profile and for whom substance-abuse data were available. Demographic characteristics and mental health history of the participants are presented in Table 1. These data were collected at the time of the intake interview and were gathered through self-report, and where possible, corroborated by previous treatment records. For participants producing a valid MMPI-2, comparisons were made on the basis of demographic characteristics and mental health history between clients included in the study (those who had a valid MMPI-2 and relevant substance-abuse data) and clients excluded from the study (those who produced a valid MMPI-2 but for whom substance-abuse data were not available). On the demographic and mental health variables as presented in Table 1, we found no significant differences between those clients included in and those excluded from the study. Table 1 Characteristics of Participants Characteristic Age M SD Years of education M SD Ethnicity (%) Caucasian African American/Other Marital status (%) Never married Divorced Married Separated Widowed Employment status (%) Unemployed Full time Part time Disabled Other Demographics tal Health Previous psychiatric hospitalizations (%) Previous outpatient treatment (%) Any Axis I diagnosis (%) Specific Axis I diagnoses (%) Adjustment disorder Depression Anxiety disorders Substance abuse/dependence Any Axis II diagnosis (%) Axis V current level of functioning M SD (n = 500) 32.82 10.08 12.10 2.10 21 35 26 23 133 47 18 13 4 18 27 58 99 32 30 16 12 30 62.83 10.08 (n = 333) 33.63 10.93 11.98 2.03 78 22 47 23 17 11 2 43 27 11 7 12 29 44 99 25 20 16 19 27 63.31 10.04

STEIN, GRAHAM, BEN-PORATH, AND McNULTY Instruments MMPl-2. The MMPI-2 (Butcher et al., 1989), a revised and updated version of the original MMPI (Hathaway & McKinley, 1940), is a 567-item personality inventory. The MMPI-2 includes the validity and clinical scales of the original MMPI, as well as new content, supplementary, and validity scales. Adequate internal consistencies and test-retest reliabilities of the MMPI-2 scales are reported in the test manual (Butcher et al., 1989) along with preliminary validity information. Internal-consistency coefficients on are a =.45 for women and a =.56 for men, based on the normative sample (Butcher et al., 1989). Also on the basis of the normative sample, test-retest reliabilities for a 1-week interval are r =.78 for women and r =.62 for men on (Butcher et al., 1989). Although Weed et al. (1992) reported no internalconsistency coefficient for on a combined sample of substance abusers, psychiatric patients, and normative subjects, a =.74 for (Graham, 1993). According to Weed et al., on the basis of the normative sample, test-retest reliabilities for a 1-week interval are r =.77 for women and r =.69 for men on and r =.84 for women and r =.89 for men on. Although they share no items, the Pearson product-moment correlation coefficient between and is r =.33 for normative participants, r =.33 for a psychiatric sample, and r =.36 for a substanceabuse sample (Weed et al.). Intake form. An intake form was designed for the larger study (Graham et al., in press) and was completed by a trained intake worker on the basis of a personal interview with each client.' Intake workers consisted of psychologists, nurses, and social workers and were highly experienced in interviewing. Data from the intake form included in this study were the demographic information (e.g., age, education, marital status, employment status, and race), selected information concerning mental health history (e.g., psychiatric hospitalizations and outpatient treatment), diagnosis, and substance-abuse history. Intake workers inquired regarding participants' past and current experience with alcohol, marijuana, cocaine, heroin, and other substances. For each substance, ratings were made on a 4-point Likert scale as follows: 1 (no use), 2 (some use), 3 (possible abuse), and 4 (definite abuse). During several training sessions, intake workers were instructed to limit the definite abuse category to those clients for whom they had great confidence that substance abuse was a problem. The possible abuse category was to be used with clients for whom there was strong indication of substance abuse, but for whom intake workers were unsure as to whether a rating of definite abuse applied. The some-use rating was to be used when some substances had been used but not to levels that had impacted the client's life adversely. The no-use category was reserved for clients who abstained from substances. Before substance-abuse ratings were made on the intake form, specific information regarding past and present use of specific substances was obtained. Information was gained through an in-depth interview, and where possible, previous treatment records. Inquiries regarding substance abuse dealt with frequency, amount, and duration for specific substances, as well as negative effects of use. Procedure Intake forms were completed following an extensive interview conducted at the time clients requested services. Interviewers were instructed to structure the interview around the intake form. Each client completed the MMPI-2 shortly after an intake interview. The median number of days between intake and completion of the MMPI-2 was 7. Ratings of each of the specific substances were combined into a single substance-abuse index by assigning the maximum rating for any substance as the overall indicator of substance abuse. For example, if a client had abuse ratings of 1 for alcohol, 3 for marijuana, 2 for cocaine, 1 for heroin, and 3 for other substances, an overall substance-abuse rating of 3 was recorded for that client. Participants were assigned to one of four substance use groups based on this variable. For women, the average substance-abuse rating was M = 2.3 and SD = 0.93 (with Mdn = 2 and mode = 2), whereas, for men, M = 2.6 and SD = 0.99 (with Mdn = 2 and mode = 2). Results Table 2 presents mean scores and standard deviations on the,, and for participants grouped by substanceabuse rating. T scores were derived based on the normative sample (see Butcher et al., 1989). As reported in Table 2, analysis of variance (ANOVA) indicated, for both genders, that the four groups differed significantly for each substance-abuse scale. Table 2 also reports the results of post hoc t tests and their associated effect sizes. For both genders and all three scales, differences between no use and all other substance-abuse groups were statistically significant. Similarly, for both genders and for all three scales, differences between some use and definite abuse were statistically significant. Examining data for women and men, for both the and scale but not for the, differences between possible abuse and definite abuse were statistically significant. For both genders, only for the was the difference between some use and possible abuse statistically significant. In addition, for both genders, effect sizes were generally largest for. Before conducting a series of hierarchical regressions, intercorrelations among,, and scores, and substanceabuse ratings were examined (see Table 3). The positive but modest correlations between scales suggest that they are not completely redundant. For men and women, the highest correlations were between and (r =.49 for women; r =.45 for men) and between and substance-abuse rating (r =.52 for women; r =.50 for men). These data indicate that although and are moderately intercorrelated, the ability of to add to the identification of substance abuse beyond is not attenuated substantially by shared variance among these scales. To test the incremental contribution of the and the to the identification of substance abuse, we conducted a series of hierarchical regression analyses, with substance-abuse rating as the dependent variable. As reported in Table 4, the independent variables were entered in three blocks. The scale was entered in the first block. was entered in the second block to test its incremental contribution in predicting substance abuse beyond. was entered in the third block to test its incremental contribution beyond and. For men and women, added significantly to the variance in substance abuse accounted for by the scale alone, whereas the addition of the produced a significant contribution for women only. In the second set of analyses presented in Table 5, the order of entry for and was reversed. For both genders, the addition of both and contributed significantly to the proportion of variance in rated substance abuse. To evaluate the accuracy with which the substance-abuse scales could classify participants as abusers or nonabusers, we calculated the positive and negative predictive powers, sensitivity, specificity, and overall classification accuracy of the 1 A copy of the intake form is available, on request, from L. A. R. Stein, Center for Alcohol and Addiction Studies, Box G-BH, Brown University, Providence, Rhode Island 022.

Table 2 Substance-Abuse Scores for Four Substance-Abuse Groups SUBSTANCE ABUSE AND THE MMPI-2 97 Substance-abuse group No use Some use Possible abuse Definite abuse " M SD M SD M SD M SD df Significant group differences'" 18.80 3.32 20.34 4.18 267 21 4.03 67 23.06 4.73 81 15.95** 3,4 a (0.39), b (0.68), c (0.22), e (0.63), f (0.40) 49.77 9.29 56.34 10.62 267 63.19 11.38 67 71.19 13.97 81 59.** 3,4 a (0.64), b (1.31), c (1.81), d (0.64), e(1.29), f (0.62) 47 9.69 51. 10.05 267 55 9.61 67 56.10 10.73 81 12.77** 3,4 a (0.46), b (0.81), c (0.), e (0.41) 19.41 3. 32 22.54 4.11 153 23.50 4.00 58 25.84 4.92 90 20.87** 3,329 a (0.77), b (1.04), c (1.38), e (0.75), f (0.51) 46.22 7.69 32 52.99 9.83 153 60.31 10 58 65.18 13.34 90 36.80** 3,329 a (0.71), b (1.51), c (1.56), d(0.74), e (1.08), f (0.40) 45.34 10.11 32 51.26 10.97 153 55.17 10.42 58 56.60 10.47 90 11.05** 3,329 a (0.55), b (0.95), c (1), e (0.50) Note. = MacAndrew Alcoholism Revised; = Addiction Acknowledgment ; = Addiction Potential. " is in raw score as is traditionally the case (see Graham, 1993); and are in linear T scores. b Significant group differences are as follows: a = mean MMPI-2 scale scores are significantly different (p.022) between no use and some use groups; b = mean MMPI-2 scale scores are significantly different (p.001) between no use and possible abuse groups; c = mean MMPI-2 scale scores are significantly different (p.001) between no use and definite abuse groups; d = mean MMPI-2 scale scores are significantly different (p.001) between some use and possible abuse groups; e = mean MMPI-2 scale scores are significantly different (p ^.006) between some use and definite abuse groups; f = mean MMPI-2 scale scores are significantly different (p &.042) between possible abuse and definite abuse groups. Numbers within parentheses are effect sizes for the post hoc tests and are expressed as d. **p <.001. scales, using data from those participants about whom we had definitive data. As stated above, all participants were rated on a 4-point scale. Participants rated at the two extremes of this scale (no use and definite abuse) were clearly nonabusers or abusers of substances. Because of ambiguity regarding those rated at the two intermediate levels (some use and possible abuse), they were not included in the classification analyses. Although this procedure reduced the sample size (N = 166 for women; N = 122 for men), it eliminated ambiguity resulting in Table 3 Pearson Product-Moment Correlation Coefficients Between Substance-Abuse s and Substance-Abuse Rating Rating _ 0.45*** 0.36*** 0.39*** 0.49*** 0.37*** 0.50*** 0*** 0.29*** 0.29*** Rating 0.30*** 0.52*** 0.26*** Note. Correlations involving MacAndrew Alcoholism Revised () were computed using raw scores, those for Addiction Acknowledgment () and Addiction Potential () were computed using linear T scores. Correlations above the diagonal refer to women, those below the diagonal refer to men. ***/> <.0005. a more precise evaluation of the classification accuracy of the MMPI-2 substance abuse scales. Table 6 shows the classification accuracy analyses using the Table 4 Predicting Substance Abuse From Hierarchical Regression Analyses: Addiction Potential () Entered Last s entered 8 R.30.52.53.39.53.54 K 2.29 p2 "adjusted ANOVA F(l,498) = 47.31** F(2, 497) = 90.75** ''change ~~ l.vj F(3, 4) = 63.87** Change = 7-68* f(l, 331) = 58.94** F(2, 330) = 65.31** ^change = 60.94** F(3, 329) = 44.51** Change = 2.37 Note. ANOVA = analysis of variance. a MacAndrew Alcoholism Revised () is in raw score; Addiction Acknowledgment () and are in linear T score. */><.006. **;><.001.

98 STEIN, GRAHAM, BEN-PORATH, AND McNULTY Table 5 Predicting Substance Abuse From Hierarchical Regression Analyses: Addiction Acknowledgment () Entered Last entered" R.30.35.53.39.42.54 R 2.12.18.29 "adjusted.12.17 ANOVA F(l, 498) = 47.31** F(2, 497) = 33.95** Change = 18.90** F(3,4) = 63.87** Change = 108.** F(l, 331) = 58.99** F(2, 330) = 35.65** F =10 S9** r change 1U.J7 F(3, 329) = 44.51** F change = 51.36** Note. ANOVA = analysis of variance. " MacAndrew Alcoholism Revised () is in raw score; and Addiction Potential () are in linear T score. ** p <.001. resulting base rate of 49% for women and base rate = 74% for men. These percentages reflect the base rate of substance abuse found in the smaller sample of participants for whom substanceabuse ratings were unambiguous (i.e., ratings of 1 or 4). Generally, overall hit rates for women and men were rather poor for the and (ranging from 47% to 69%). For women, T score on yielded the best overall hit rate (%) with a sensitivity of %, a specificity of 87%, and positive and negative predictive powers of % each. For men, T score a60 on yielded the best overall hit rate (76%) with a sensitivity of 71%, a specificity of %, and positive and negative predictive powers of % and 53%, respectively. Because the actual base rates obtained in the narrower sample were unrealistically high, analyses were again conducted on the participants for whom substance-abuse ratings were unambiguous; however, base rates were adjusted (Meehl & Rosen, 1955) to reflect the base rate of substance abuse found in the larger sample of participants (N = 500 for women; N 333 for men). These results are reported in Table 7. Generally, overall hit rates were acceptable for both women and men on and (ranging from 76% to %). For women, T score on yielded the best overall hit rate (92%) with a sensitivity of 69%, a specificity of %, and positive and negative predictive powers of % and 94%, respectively. For men, T score 5:60 on yielded the best overall hit rate (%) with a sensitivity of 71%, a specificity of %, and positive and negative predictive powers of 74% and 89%, respectively. Table 6 Sensitivity, Specificity, Positive Predictive Power (PPP), Negative Predictive Power (NPP), and Overall Hit Rate in Percentages cutoff 3 Sensitivity 36 14 69 46 21 61 33 71 54 48 29 Specificity 93 87 81 97 PPP 83 95 82 90 94 93 NPP 60 55 77 64 56 43 35 53 41 38 33 Overall hit rate Note. For women, base rate = 49%, and for men, base rate = 74%. " MacAndrew Alcoholism Revised () raw score is based on Gottesman and Prescott (1989); raw score is based on Graham (1993). Addiction Acknowledgment () and Addiction Potential () linear T score is based on Graham (1993); and linear T score a65 is based Butcher et al. (1989). 65 58 83 69 60 66 51 76 64 59 47 Table 7 Sensitivity, Specificity, Positive Predictive Power (PPP), Negative Predictive Power (NPP), and Overall Hit Rate in Percentages cutoff" Sensitivity 36 14 69 46 21 61 33 71 54 48 29 Specificity 93 87 81 97 PPP 50 56 48 53 55 74 68 65 77 NPP 88 97 94 90 80 89 84 82 Overall hit rate Note. For women, base rate = 16%, and for men, base rate = 27%. "MacAndrew Alcoholism Revised () raw score is based on Gottesman and Prescott (1989); raw score is based on Graham (1993). Addiction Acknowledgment () and Addiction Potential () linear T score 60 is based on Graham (1993); and linear T score is based Butcher et al. (1989). 84 87 92 83 84 76 82 81

SUBSTANCE ABUSE AND THE MMPI-2 99 Discussion Scores on the three MMPI-2 substance abuse scales,,, and, were related to interviewer ratings of substance abuse in.this outpatient mental health sample. The three scales differentiated significantly between individuals identified by experienced interviewers as evidencing varied levels of substance abusive behavior. Hierarchical regression analyses indicated that added significantly and substantially to and in predicting variance in substance abuse and that added only modestly to on this task in this sample. Although classification accuracy analyses indicated that and yielded acceptable overall hit rates, produced the best classification rates in this sample. explained a modest, but significant amount of variance in substance use and abuse (about 10% and 15% for women and men, respectively). For women and men, added substantially to the amount of variance explained by alone (variance increased by 18% and 13% for women and men, respectively). The addition of to and did not add as much information to the amount of variance in substance abuse explained. Similarly, whereas the addition of to was statistically significant, variance increased by only 3% for women and 2% for men. Finally, predicted a statistically significant and substantial proportion of additional variance beyond and (variance increased by 15% and 11% for women and men, respectively). The amount of variance in substance use and abuse explained by all three scales in the regression equation was a little less than 30%, which suggests that these scales have practical utility in screening for substance abusive behavior in outpatient mental health settings. The overall hit rates obtained in the classification accuracy analyses were higher when base rates were adjusted to reflect the base rate of substance abuse in the total sample (N = 500 for women; N = 333 for men). As compared with base rate = 49% for women and base rate = 74% for men, adjusted base rates of 16% and 27% for women and men, respectively, may be more realistic estimates of the base rates of substance abuse found in outpatient settings. For both genders, a cutoff of 28 provided the highest overall accurate classification rate on. The positive and negative predictive powers were high; however, sensitivity was poor for both genders. For women, optimal classification accuracy was found on at a T-score cutoff of 65, whereas for men, the optimal r-score cutoff was 60 on. For both genders, all four accuracy indicators were acceptably high. Overall classification accuracy was equal at T-score cutoffs of 60 and 65 for both women and men on. However, positive predictive power was poor for women at both cutoffs and acceptable for men only at a cutoff of 65. These classification accuracy analyses indicate that an elevated score on any of these scales in outpatient mental health settings should alert clinicians to obtain more data regarding the possibility of substance abuse. The higher the score, the greater the possibility of substance-abuse problems. The hierarchical regression results indicate that scores on these scales are not completely redundant, and therefore, each of the scales warrants examination when screening for a possible substance-abuse problem in outpatient mental health clients. The finding that demonstrated the greatest effect size in this sample warrants further consideration. This brief, face valid content-based scale consists primarily of items related overtly to substance abusive behavior. As its label implies, individuals with elevated scores on this scale are acknowledging problems in the area of substance abuse. The current results are consistent with previous research, indicating that content-based scales can provide incrementally valid information when compared with empirically keyed scales. Archer, Elkins, Aiduk, and Griffin (1997); Ben-Porath, Butcher, and Graham (19); and Ben-Porath, Mc- Cully, and Almagor (1993) have reported similar findings for the MMPI-2 Content s compared with the empirically keyed clinical scales. The finding that adds incrementally to the empirically keyed and scales provides further evidence of the importance of considering item content themes in MMPI-2 interpretation. As is the case with the MMPI-2 Content s, the transparent nature of the items imposes limitations on its interpretability. Although this study did not address the susceptibility of the substance abuse scales to distortion, for obvious reasons, content scales may be more susceptible to intentional distortion than empirically keyed ones. Therefore, it is of particular importance to examine scores on the validity scales of the MMPI-2 before interpreting. A defensive test-taking approach is likely to result in artificially low scores on and other content scales. Moreover, even if a general defensive approach to the test is not indicated, it remains possible that some test-takers would be reluctant to acknowledge problems specifically in the area of substance abuse. Therefore, the absence of elevation on this scale cannot be taken as a negative indicator of substance abuse. Thus, higher scores on can be used to suggest the possibility of substance-abuse difficulties in outpatient mental health settings; however, low scores on this scale cannot be used to rule this problem out. Future studies may address the effects of defensive test-taking style on the substance abuse scales. Findings regarding indicate a significant, but perhaps, more limited role for this scale in detecting substance-abuse problems in outpatient settings. Results for this scale were generally comparable to those of the scale. Unlike the findings reported by Weed et al. (1992), the present results do not point to a substantial contribution of beyond in identifying substance abuse in this setting. Population differences may account for the discrepant findings. Participants in the Weed et al. study came from two different types of settings: an inpatient facility devoted exclusively to substance-abuse treatment and a number of inpatient psychiatric units. It is possible that is better able to differentiate between individuals more clearly identified as having either substance-abuse or significant psychiatric difficulties than it can distinguish among outpatients, all receiving mental health services and some of whom have secondary substance-abuse problems. A limitation of our study concerns the broad definition used for rating substance abuse. Our substance-abuse variable did not measure a specific class of substances. Significant levels of comorbidity precluded breaking our sample down into mutually exclusive alcohol- or drug-abuse subsamples. Consequently, the ability of the MMPI-2 substance abuse scales to identify alcohol-only or drug-only abuse could not be examined here and remains to be studied in future investigations. Another limitation of this study is

STEIN, GRAHAM, BEN-PORATH, AND McNULTY that both interrater reliability and temporal stability data were unavailable regarding substance-abuse ratings by intake workers. It was simply unrealistic for intake workers at this large community mental health center to conduct two interviews per client on a subsample of participants for this field study. In addition, future studies may measure substance use and abuse using methods other than intensive interview data. For example, standardized instruments may be used as may reports from significant others. In summary, the current findings indicate that scores on the MMPI-2 substance abuse scales are related to rated substance abuse in an outpatient mental health setting. These results illustrate that the utility of the recently developed and scales generalizes beyond inpatient settings where they were initially constructed and studied. Identifying potential substance-abuse problems in individuals referred primarily for outpatient mental health services is important to the development of a successful treatment plan. The MMPI-2 substance abuse scales can play a significant role in this process. There may be times when a client is not honest in an interview but is honest on a test that does not involve face to face contact, and this argues for the usefulness of testing. This study depended in part on the truthfulness of the client and the skill of the interviewer in determining substance abuse, even when perhaps the client was reluctant to divulge information. However, there may be times when a more skillful and experienced interviewer is unavailable to conduct a thorough interview, and testing can alert professionals to areas needing more attention. The MMPI-2 can also assist in streamlining following interviews. This study indicates that the MMPI-2 is useful in screening for substance abuse in outpatient mental health settings where substance abuse is not the primary reason for referral. References Archer, R. P., Elkins, D. E., Aiduk, R., & Griffin, R. (1997). The incremental validity of MMPI-2 Supplementary scales. Assessment, I, 193-205. Ben-Porath, Y. S., Butcher, J. N., & Graham, J. R. (19). Contribution of the MMPI-2 Content scales to the differential diagnosis of schizophrenia and major depression. Psychological Assessment, 3, 634-640. Ben-Porath, Y. S., McCully, E., & Almagor, M. (1993). Incremental validity of the MMPI-2 Content scales in the assessment of personality and psychopathology by self-report. Journal of Personality Assessment, 61, 557-575. Butcher, J. N., Dahlstrom, W. G., Graham, J. R., Tellegen, A., & Kaemmer, B. (1989). MMPI-2: Manual for administration and scoring. Minneapolis: University of Minnesota Press. Butcher, J. N., Graham, J. R., & Ben-Porath, Y. S. (1995). Methodological problems and issues in MMPI, MMPI-2, and MMPI-A research. Psychological Assessment, 7, 320 329. Gottesman, I. I., & Prescott, C. A. (1989). Abuses of the MacAndrew MMPI Alcoholism scale: A critical review. Clinical Psychology Review, 9, 223-242. Graham, J. R. (1993). MMPI-2: Assessing personality and psychopathology (2nd ed.). New York: Oxford University Press. Graham, J. R., Ben-Porath, Y. S., & McNulty, J. L. (in press). Using the MMPI-2 in outpatient mental health settings. Minneapolis: University of Minnesota Press. Graham, J. R., & Stronger, V. E. (1988). MMPI characteristics of alcoholics: A review. Journal of Consulting and Clinical Psychology, 56, 197-205. Graham, J. R., Watts, D., & Timbrook, R. E. (19). Detecting fake-good and fake-bad MMPI-2 profiles. Journal of Personality Assessment, 57, 264-277. Greene, R. L., Weed, N. C., Butcher, J. N., Arrendondo, R., & Davis, H. G. (1992). A cross-validation of MMPI-2 Substance Abuse scales. Journal of Personality Assessment, 58, 405-410. Hathaway, S. R., & McKinley, J. C. (1940). A multiphasic personality schedule (Minnesota): I. Construction of the schedule. Journal of Psychology, 10, 249-254. MacAndrew, C. (15). The differentiation of male alcoholic outpatients from nonalcoholic psychiatric outpatients by means of the MMPI. Quarterly Journal of Studies on Alcohol, 26, 238-246. MacAndrew, C. (1981). What the MAC scale tells us about alcoholics: An interpretive review. Journal of Studies on Alcohol, 42, 604-625. Meehl, P. E., & Rosen, A. (1955). Antecedent probability and the efficiency of psychometric signs, patters, or cutting scores. Psychological Bulletin, 52, 194-216. Weed, N. C., Butcher, J. N., McKenna, T., & Ben-Porath, Y. S. (1992). New measures for assessing alcohol and drug abuse with the MMPI-2: The and. Journal of Personality Assessment, 58, 389-404. Received April 7, 1998 Revision received October 22, 1998 Accepted October 26, 1998